Torrent Pharma logs 11% y-o-y growth in Q4 net profit

21 May 2025 , 11:02 AM

Torrent Pharmaceuticals Limited announced its results for the quarter ended March 2025 and posted robust performance for the quarter under review. The business registered a net profit of ₹498 Crore. It registered a growth of 10.90% on a year-on-year basis against ₹449 Crore in the previous corresponding period.

The revenue witnessed a growth of 7.80% on a year-on-year basis at ₹2,959 Crore. In the previous comparable period, the business posted a revenue of ₹2,745 Crore. The business said that growth was fueled by growth throughout key geographies and therapeutic segments.

On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24. The company also informed that operating margins came in at 32.60% against 32.20% in the previous period under review. 

For the financial year ended March 2025, the business said that the board has recommended a final dividend of ₹6 per equity share (120%). Prior to this, the business also announced an interim dividend of ₹26 per share.

The board also proposed resolutions to raise as much as ₹5,000 Crore via qualified institutional placement (QIP) or other sources, subject to approval of shareholders.

For feedback and suggestions, write to us at [e-mail]